Common Contracts

1 similar null contracts

RavenQuest BioMed Inc. (CSE: RQB) (OTCQB: RVVQF) (Frankfurt: 1IT) – B.C. Supply Agreement and Micro-Cultivator Investment
August 2nd, 2018
  • Filed
    August 2nd, 2018

⮚ RavenQuest Biomed Inc. (“RavenQuest”, “company”) reported Q2-FY2019 (quarter ended April 30, 2018) revenues of $614,360, growing 0.48% QoQ. The are no comparable YoY figures.

AutoNDA by SimpleDocs
Time is Money Join Law Insider Premium to draft better contracts faster.